-
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES TrialM Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators. -
Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA EditorsAK Gupta, H Jneid, B London et al.
-
Coronary Artery Calcium Is Associated with Left Ventricular Diastolic Function Independent of Myocardial IschemiaNitta K, Kurisu S, Nakamoto Y et al.
-
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic RiskPM Ridker
-
Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-upIqbal J, Zhang YJ, Serruys PW et al.
-
Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular DiseaseRosenson RS, Davidson MH, Hirsh BJ et al.
-
Percutaneous Coronary Intervention Readmissions Where Are the Solutions?Kalra A, Shishehbor MH, Simon DI.
-
Impact of Artificial Intelligence on Interventional Cardiology: From Decision-Making Aid to Advanced Interventional Procedure AssistanceP Sardar, JD Abbott, A Kundu et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
